SEC Form 4 · accession 0001209191-15-071254
AGIOS PHARMACEUTICALS, INC. · AGIO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John Duncan Higgons
Officer — Chief Operating Officer
Period of report
Sep 15, 2015
Accepted (ET)
Sep 17, 2015 · 6:39 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001439222
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock | Sep 15, 2015 | M | 2,480 | $0.3025 | A | 144,315 | D | |
| Common stock | Sep 15, 2015 | M | 17,520 | $0.3025 | A | 161,835 | D | |
| Common stockF3 | Sep 15, 2015 | S | 20,000 | $91.11 | D | 141,835 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock option (right to buy)F4 | $0.3025 | Sep 15, 2015 | M | 2,480 | D | — | Aug 12, 2019 | Common stock | 2,480 | 272,542 | D |
| Stock option (right to buy)F5 | $0.3025 | Sep 15, 2015 | M | 17,520 | D | — | Mar 25, 2020 | Common stock | 17,520 | 255,022 | D |
Explanation of responses
- F1This exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- F2This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- F3The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $90.15 to $92.44. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F4This option was granted on August 13, 2009. The shares underlying this option vest as to 25% of the shares on June 13, 2010, with the remaining 75% vesting in 36 equal monthly installments thereafter.
- F5This option was granted on March 26, 2010 for the purchase of 36,363 shares of common stock. The option vests as to 50% of the underlying shares upon the achievement of a performance milestone and with the remaining 50% vesting in 36 equal monthly installments thereafter. The performance criteria for the performance milestone were met on June 3, 2010.